Skip to main content
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. — Investor Relations & Filings

Ticker · VKTX ISIN · US92686J1060 LEI · 529900IVC72YPFA25M37 US Professional, scientific and technical activities
Filings indexed 607 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country US United States of America
Listing US VKTX

About Viking Therapeutics, Inc.

https://vikingtherapeutics.com/

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's pipeline is centered on small molecule drug candidates designed to address these conditions.

Recent filings

Filing Released Lang Actions
10-Q - Viking Therapeutics, Inc. (0001607678) (Filer)
Interim / Quarterly Report
2026-04-30 English
SCHEDULE 13G/A - Viking Therapeutics, Inc. (0001607678) (Subject)
Major Shareholding Notification
2026-03-27 English
10-K Filing
Annual Report FY 2025
2026-02-11 English
8-K Filing
Regulatory Filings
2026-02-11 English
3 Filing
Director's Dealing
2026-01-26 English
4 Filing
Director's Dealing
2026-01-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.